Udhayvir Grewal, Resident Physician at Ochsner LSU Health Shreveport, shared a post on X:
“Next up is Dr Jen Chan from Dana-Farber News discussing emerging DLL3-targeting therapies in high grade NENs.
So many therapies/agents to look forward to- BiTE, ADCs, RLT agents, CAR-T cell therapy and more. This (EP-NEC) is a devastating disease in desperate need of better therapies.”
Other articles featuring Dr. Grewal on OncoDaily.
